Skip to content

Mental Health in Primary Care

Scaling a Parenting Evidence Based Intervention (EBI) for Latinx Youth Mental Health in Primary Care

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05426057
Enrollment
468
Registered
2022-06-21
Start date
2022-04-26
Completion date
2028-04-30
Last updated
2026-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression, Anxiety, Drug Use, Suicide

Keywords

effectiveness-implementation type 1 hybrid trial, Latinx mental health in primary care, Latinx adolescent, eHealth intervention, Familias Unidas, intervention sustainment, parent-centered, family functioning, sexual risk behavior

Brief summary

The goal of this study is to evaluate in an effectiveness-implementation type I hybrid trial, an enhanced version of eHealth Familias Unidas for reducing depressive, anxious symptoms and suicide behavior in Hispanic youth. The study will use a randomized rollout design with 18 pediatric primary care clinics in the South Florida area.

Interventions

BEHAVIORALeHealth Familias Unidas Mental Health

eHealth Familias Unidas is a program designed to target mental health and suicide ideation and behavior. It focuses on promoting mental health by strengthening family and interpersonal protective factors. The program is provided online over a total of 13 sessions: 9 video parent group sessions, each lasting 20-40 minutes in Spanish and 4 web family sessions lasting 45 minutes in either Spanish or English, depending on participant language preference. The video parent group sessions consist of: 1) culturally syntonic telenovela/soap opera series, 2) videotaped parent group discussions, 3) interactive exercises. Web family sessions will be conducted by a trained pediatric staff member.

Sponsors

University of Miami
Lead SponsorOTHER
National Institute of Mental Health (NIMH)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
12 Years to 16 Years
Healthy volunteers
Yes

Inclusion criteria

1. Female and male adolescents, who self-identify as Hispanic (or Latino(a)) 2. Adolescent between the ages of 12 - 16 years 3. Adolescent living with an adult primary caregiver who is willing to participate 4. Families must have broadband internet access on a device, including (but not limited to) a smartphone, iPad, tablet, computer at their home or other location (e.g., school, library, etc.) 5. Families screening positive on poor family communication (a score of less than 75 on the communication measure; see measures) or youth reporting elevated depressive or anxiety symptom scores (defined as 70 to 90 on the K-CAT) or a history of suicide behavior (ideation or attempts).

Exclusion criteria

* Families reporting plans to move out of the South Florida area during the study period.

Design outcomes

Primary

MeasureTime frameDescription
Depression symptomsBaseline to 3 months, baseline to 6 months, baseline to 18 monthsChange in depression symptom severity will be measured using the Kiddie Computerized Adaptive Test (K-CAT®). K-CAT® measures severity on a scale of 0 to 100 with higher scores indicating greater depression symptom severity.
Anxiety symptomsBaseline to 3 months, baseline to 6 months, baseline to 18 monthsChange in anxiety symptom severity will be measured using the Kiddie Computerized Adaptive Test (K-CAT®). K-CAT® measures severity on a scale of 0 to 100 with higher scores indicating greater anxiety symptom severity.
SuicidalityBaseline to 3 months, baseline to 6 months, baseline to 18 monthsChange in suicidality severity will be measured using the Kiddie Computerized Adaptive Test (K-CAT®). K-CAT® measures severity on a scale of 0 to 100 with higher scores indicating greater suicidality symptom severity.
Change in drug useBaseline to 3 months, baseline to 6 months, baseline to 18 monthsChange in drug use will be reported as the number of days drug use was reported over the last 90 days.
Center for Epidemiologic Studies Depression Scale (CESD)Baseline to 3 months, baseline to 6 months, baseline to 18 monthsChange in depression symptoms will be assessed with the CESD. Scores range from 0 to 60 with higher scores indicating the presence of more symptoms.

Secondary

MeasureTime frameDescription
Change in Family Functioning as assessed by the Parenting Practices QuestionnaireBaseline to 3 months, baseline to 6 months, baseline to 18 monthsChange in family functioning will be reported using nine items from the Parenting Practices Questionnaire . Response range varies based on questions, but most response items range from 0 to 4 with higher values indicating better parenting. Scores range from 0 to 36.
Change in Family Functioning as assessed by the Parent Relationship with Peer GroupBaseline to 3 months, baseline to 6 months, baseline to 18 monthsChange in family functioning will be reported using the Parent Relationship with Peer Group. The Parent Relationship with Peer Group is a six item measure with response items ranging from 0 to 24. Higher scores indicate better outcomes.
Change in Family Functioning as assessed by the Parent-Adolescent Communication ScaleBaseline to 3 months, baseline to 6 months, baseline to 18 monthsChange in family functioning will be reported using the Parent-Adolescent Communication Scale. The Parent-Adolescent Communication Scale is a twenty-item questionnaire with a total score ranging from 20 to 100 with higher scores indicating better communication.
Change in unprotected sexual behaviorBaseline to 3 months, baseline to 6 months, baseline to 18 monthsChange in unprotected sexual behavior will be reported as number of days of sex without a condom as reported over the last 90 days.

Countries

United States

Contacts

CONTACTGuillermo Prado, PhD
gprado@miami.edu305-284-2002
CONTACTYannine Estrada, PhD
yestrada@miami.edu305-284-6191
PRINCIPAL_INVESTIGATORGuillermo Prado, PhD

University of Miami

PRINCIPAL_INVESTIGATORC. Hendricks Brown, PhD

Northwestern University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 19, 2026